Category: Press Release

Applied DNA Sciences Announces Private Placement of Up To $58 Million To Initiate BNB Treasury Strategy and BNB Native Yield Generation

September 29th, 2025

Applied DNA Abstracts Selected for Poster Presentations Showcasing LineaDNA and LineaIVT Platforms at Upcoming mRNA and CAR T Industry Conferences

September 23rd, 2025

Applied DNA Reports Third Quarter Fiscal 2025 Financial Results

August 14th, 2025

Applied DNA Announces New Follow-On LineaDNA™ Order from Global IVD Manufacturer for Use in Cancer Diagnostic Application

July 24th, 2025

Applied DNA Regains Compliance with All Nasdaq Continued Listing Requirements

July 7th, 2025

Applied DNA Sharpens Strategic Focus on Synthetic DNA Manufacturing for Biotherapeutics Applications, Consolidates Operations Behind LineaRx

June 30th, 2025

Applied DNA to Resume Quarterly Investor Call Cadence Beginning with FQ3’25 Financial Results Report in Mid-August

June 16th, 2025

Applied DNA Reschedules Intra-Quarter Webcast and Investor Update Call to June 17

May 29th, 2025

Applied DNA Announces 1-For-15 Reverse Stock Split Effective June 2, 2025

May 29th, 2025